应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KDNY Chinook Therapeutics, Inc.
停牌 12-26 09:40:53 EST
40.39
+0.00
0.00%
最高
40.39
最低
40.39
成交量
0.00
今开
40.39
昨收
40.39
日振幅
0.00%
总市值
29.00亿
流通市值
24.39亿
总股本
7,180万
成交额
0.00
换手率
0.00%
流通股本
6,039万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
诺华宣布收购Chinook Therapeutics,预计将于下半年完成
界面 · 2023-06-13
诺华宣布收购Chinook Therapeutics,预计将于下半年完成
Chinook Therapeutics Inc股价上涨57.82% 市值涨14.64亿美元
自选股智能写手 · 2023-06-12
Chinook Therapeutics Inc股价上涨57.82% 市值涨14.64亿美元
诺华制药拟35亿美元收购Chinook Therapeutics,扩大肾脏药物产品线
智通财经 · 2023-06-12
诺华制药拟35亿美元收购Chinook Therapeutics,扩大肾脏药物产品线
加载更多
公司概况
公司名称:
Chinook Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Chinook Therapeutics, Inc.是一家临床阶段生物技术公司,开发肾脏疾病的精确药物。公司的候选产品正在研究罕见的,严重的慢性肾脏疾病的机会,明确的临床途径。公司的主要项目是阿特拉森坦,一种用于治疗IgA肾病和其他原发性肾小球疾病的研究性3期内皮素受体拮抗剂。
发行价格:
--
{"stockData":{"symbol":"KDNY","market":"US","secType":"STK","nameCN":"Chinook Therapeutics, Inc.","latestPrice":40.39,"timestamp":1735224053483,"preClose":40.39,"halted":3,"volume":0,"delay":0,"floatShares":60387030,"shares":71804977,"eps":-3.516501,"marketStatus":"停牌","marketStatusCode":2,"change":0,"latestTime":"12-26 09:40:53 EST","open":40.39,"high":40.39,"low":40.39,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.516501,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1735246800000},"adr":0,"listingDate":1429070400000,"adjPreClose":40.39,"volumeRatio":0,"impliedVol":0.098,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/KDNY","defaultTab":"news","newsList":[{"id":"2343459876","title":"诺华宣布收购Chinook Therapeutics,预计将于下半年完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2343459876","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2343459876?lang=zh_cn&edition=full","pubTime":"2023-06-13 18:04","pubTimestamp":1686650673,"startTime":"0","endTime":"0","summary":"6月13日,据诺华集团消息,诺华日前宣布已经达成一项协议,将收购一家专注于临床阶段的生物制药公司Chinook Therapeutics。该项交易金额高达35亿美元(包括每股40美元的现金,以及每股最高4美元的或有价值权),已获诺华和Chinook董事会批准,在符合惯例成交条件下,预计将于2023年下半年完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023061318043382d2469c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023061318043382d2469c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KDNY","BK4578","IE0009355771.USD","BK4532","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0211331839.USD","BK4007","IE00B2B36J28.USD","BK4139","NVS","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2342634351","title":"Chinook Therapeutics Inc股价上涨57.82% 市值涨14.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2342634351","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2342634351?lang=zh_cn&edition=full","pubTime":"2023-06-12 21:31","pubTimestamp":1686576672,"startTime":"0","endTime":"0","summary":"北京时间2023年06月12日21时31分,Chinook Therapeutics Inc股票出现波动,股价快速拉升57.82%。Chinook Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.67%。Chinook Therapeutics Inc公司简介:ChinookTherapeutics Inc是一家临床阶段的生物技术公司。消息层面,截至21时31分,Chinook Therapeutics Inc股票正面舆情新闻比例75%。《诺华制药 拟35亿美元收购Chinook Therapeutics 扩大肾脏药物产品线》资讯为影响Chinook Therapeutics Inc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023061221311282744062&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023061221311282744062&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KDNY"],"gpt_icon":0},{"id":"2342250760","title":"诺华制药拟35亿美元收购Chinook Therapeutics,扩大肾脏药物产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=2342250760","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2342250760?lang=zh_cn&edition=full","pubTime":"2023-06-12 15:05","pubTimestamp":1686553508,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,瑞士制药巨头诺华制药 计划以高达35亿美元的价格收购位于华盛顿州西雅图的生物制药公司Chinook Therapeutics。此次收购完全符合诺华专注于创新药物的战略,并将显著扩大其肾脏产品组合,补充现有产品线。诺华首席执行官Vas Narasimhan表示,此次收购解决社会上最具挑战性的医疗保健问题之一,为年轻患者提供了独特机会。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/944104.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","IE0002141913.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","KDNY","BK1191","LU0211331839.USD","BK4139","IE00BFTCPJ56.SGD","BK4578","IE0009355771.USD","BK1574","BK4532","IE00BJT1NW94.SGD","NVS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinooktx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Chinook Therapeutics, Inc.是一家临床阶段生物技术公司,开发肾脏疾病的精确药物。公司的候选产品正在研究罕见的,严重的慢性肾脏疾病的机会,明确的临床途径。公司的主要项目是阿特拉森坦,一种用于治疗IgA肾病和其他原发性肾小球疾病的研究性3期内皮素受体拮抗剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.050571},{"month":2,"riseRate":0.5,"avgChangeRate":0.153158},{"month":3,"riseRate":0.375,"avgChangeRate":0.053741},{"month":4,"riseRate":0.5,"avgChangeRate":-0.046054},{"month":5,"riseRate":0.666667,"avgChangeRate":0.077697},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.052217},{"month":7,"riseRate":0.555556,"avgChangeRate":0.022688},{"month":8,"riseRate":0.555556,"avgChangeRate":0.015005},{"month":9,"riseRate":0.125,"avgChangeRate":-0.089457},{"month":10,"riseRate":0.5,"avgChangeRate":-0.047181},{"month":11,"riseRate":0.875,"avgChangeRate":0.086951},{"month":12,"riseRate":0.444444,"avgChangeRate":0.007063}],"exchange":"NASDAQ","name":"Chinook Therapeutics, Inc.","nameEN":"Chinook Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chinook Therapeutics, Inc.(KDNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Chinook Therapeutics, Inc.(KDNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Chinook Therapeutics, Inc.,KDNY,Chinook Therapeutics, Inc.股票,Chinook Therapeutics, Inc.股票老虎,Chinook Therapeutics, Inc.股票老虎国际,Chinook Therapeutics, Inc.行情,Chinook Therapeutics, Inc.股票行情,Chinook Therapeutics, Inc.股价,Chinook Therapeutics, Inc.股市,Chinook Therapeutics, Inc.股票价格,Chinook Therapeutics, Inc.股票交易,Chinook Therapeutics, Inc.股票购买,Chinook Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chinook Therapeutics, Inc.(KDNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Chinook Therapeutics, Inc.(KDNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}